drugset / Trial / NCT04447183
The Safety and Effectiveness of rhTSH in Radioiodine Treatment for Patients With Differentiated Thyroid Cancer.
RandomizedParallel-groupOpen-labelTreatment
Summary
This is a randomized, open, parallel controlled, multi-center clinical trial; 120 subjects were randomly assigned to the test group and the control group according to 3:1.
Timeline
- Start
- 2020-11-23
- Primary completion
- 2024-08
- Completion
- 2024-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | rhTSH | Protein / enzyme biologic | 0.9 mg | Intramuscular |
| Background | Radioactive iodine | Other / unclassified | 1110 mbq | Oral |